K.C. Pharmaceuticals, Inc., based in Pomona, California, has voluntarily recalled over 3.1 million bottles of eye drops due to inadequate testing that failed to confirm their sterility and safety. The recall includes eight different brands sold under various store labels, such as Walgreens, CVS, and Kroger. Affected products have expiration dates ranging from April 30, 2026, to October 31, 2026. The FDA has received reports of infections linked to these eye drops, with symptoms including redness, eyelid sticking, unusual discharge, vision changes, and irritation. Consumers should verify their eye drop products against the recall list, ensuring both the product name and lot number match to determine if they are affected. If recalled, users should stop using the product immediately and return it for a refund. The recall has been classified as Class II by the FDA, indicating that exposure could lead to temporary or medically irreversible health consequences.